LISA FITZGERALD: Open Payments
NPI 1568942571 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,073 in 24 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $431 · 2025 $3,073
Consulting: $1,580Food & beverage: $820Travel & lodging: $576Education: $97
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 13 | $2,746 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| Baxter Healthcare | 2 | $64 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| Apellis Pharmaceuticals, Inc. | 1 | $34 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: ENVARSUS, Fabhalta, Hillrom - Vest System Model 105 Home Care, TERLIVAZ, REZDIFFRA, LIVTENCITY, XIFAXAN.
Industry payments across TX — which companies pay providers there.
